ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: May 2025
|
Report Code: QYRE-Auto-15123
Home | Market Reports | Science| Biological Sciences
Global Single Nucleotide Polymorphism SNP Genotyping Market Size Status and Forecast 2022
BUY CHAPTERS

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-15123
Report
May 2025
Pages:172
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Illumina Inc
Affymetrix Inc
Applied Biosystems
Agilent Technologies
Beckman Coulter
Roche
Qiagen NV
Luminex Corporation
Enzo Life Sciences
Bio Rad
Sequenom
Ocimum Biosolutions
GE Healthcare
GenScript
Douglas Scientific
BGI
Beijing Sunbiotech
HuaGene Biotech
Generay Biotech
Benegene
Shanghai Biochip
GENESKY
HD Biosciences

Single Nucleotide Polymorphism (SNP) Genotyping Market Size

In 2024, the global market size of Single Nucleotide Polymorphism (SNP) Genotyping was estimated to be worth US$ 24710 million and is forecast to reach approximately US$ 92750 million by 2031 with a CAGR of 21.1% during the forecast period 2025-2031.

Single Nucleotide Polymorphism (SNP) Genotyping Market

Single Nucleotide Polymorphism (SNP) Genotyping Market

Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.
Global Single Nucleotide Polymorphism (SNP) Genotyping key players include Illumina, Affymetrix, Applied Biosystems, Agilent Technologies, Beckman Coulter, etc. Global top five players hold a share about 65%.
North America is the largest market, with a share about 40%, followed by Europe and Japan, having a total share about 35 percent.
In terms of product, the segment includes Transversion, Transition. And in terms of application, the largest application is Diagnostics, followed by Animal, Plant, Research, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Single Nucleotide Polymorphism (SNP) Genotyping, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Nucleotide Polymorphism (SNP) Genotyping.
The Single Nucleotide Polymorphism (SNP) Genotyping market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Single Nucleotide Polymorphism (SNP) Genotyping market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single Nucleotide Polymorphism (SNP) Genotyping companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Single Nucleotide Polymorphism (SNP) Genotyping Market Report

Report Metric Details
Report Name Single Nucleotide Polymorphism (SNP) Genotyping Market
Forecasted market size in 2031 approximately US$ 92750 million
CAGR 21.1%
Forecasted years 2025 - 2031
Segment by Type
  • Transversion
  • Transition
Segment by Application
  • Diagnostics
  • Animal
  • Plant
  • Research
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Illumina, Affymetrix, Applied Biosystems, Agilent Technologies, Beckman Coulter, Roche, Qiagen, Luminex Corporation, Enzo Life Sciences, Bio-rad, Sequenom, Ocimum Biosolutions, GE Healthcare, GenScript, Douglas Scientific, BGI, Beijing Sunbiotech, HuaGene Biotech, Generay Biotech, Benegene, Shanghai Biochip, GENESKY, HD Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Single Nucleotide Polymorphism (SNP) Genotyping in global and regional level.
  • Chapter 3: Detailed analysis of Single Nucleotide Polymorphism (SNP) Genotyping company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Single Nucleotide Polymorphism (SNP) Genotyping revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Single Nucleotide Polymorphism (SNP) Genotyping Market size in 2031?

Ans: The Single Nucleotide Polymorphism (SNP) Genotyping Market size in 2031 will be approximately US$ 92750 million.

What is the market share of major companies in Single Nucleotide Polymorphism (SNP) Genotyping Market?

Ans: Global top five players hold a share about 65%.

Who are the main players in the Single Nucleotide Polymorphism (SNP) Genotyping Market report?

Ans: The main players in the Single Nucleotide Polymorphism (SNP) Genotyping Market are Illumina, Affymetrix, Applied Biosystems, Agilent Technologies, Beckman Coulter, Roche, Qiagen, Luminex Corporation, Enzo Life Sciences, Bio-rad, Sequenom, Ocimum Biosolutions, GE Healthcare, GenScript, Douglas Scientific, BGI, Beijing Sunbiotech, HuaGene Biotech, Generay Biotech, Benegene, Shanghai Biochip, GENESKY, HD Biosciences

What are the Application segmentation covered in the Single Nucleotide Polymorphism (SNP) Genotyping Market report?

Ans: The Applications covered in the Single Nucleotide Polymorphism (SNP) Genotyping Market report are Diagnostics, Animal, Plant, Research, Others

What are the Type segmentation covered in the Single Nucleotide Polymorphism (SNP) Genotyping Market report?

Ans: The Types covered in the Single Nucleotide Polymorphism (SNP) Genotyping Market report are Transversion, Transition

Recommended Reports

Genetic Diagnostics

Sequencing Technologies

Genomics Services

Market trends :

Topic Trends
Global the global snp genotyping market is experiencing rapid growth driven by increased adoption in diagnostics, agriculture, and research, with automation and high-throughput technologies enabling large-scale applications across multiple sectors.
Application Diagnostics - diagnostics remains the largest application segment for snp genotyping, fueled by rising demand for personalized medicine and genetic disease screening.
Region North America - north america leads the snp genotyping market due to advanced healthcare infrastructure, significant research investments, and early adoption of genomic technologies.
1 Study Coverage
1.1 Single Nucleotide Polymorphism (SNP) Genotyping Product Introduction
1.2 Market by Type
1.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Transversion
1.2.3 Transition
1.3 Market by Application
1.3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Diagnostics
1.3.3 Animal
1.3.4 Plant
1.3.5 Research
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Estimates and Forecasts
2.2 Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region: 2024 Versus 2031
2.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Region: 2020-2025
2.2.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Forecast by Region (2026-2031)
2.2.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2020-2031)
3.1.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2020-2031)
3.2.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Transversion of Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application
3.3.2 Transition of Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application
4 Global Single Nucleotide Polymorphism (SNP) Genotyping by Company
4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Company (2020-2025)
4.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Single Nucleotide Polymorphism (SNP) Genotyping Companies around the World: Ranking by Revenue
4.3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Single Nucleotide Polymorphism (SNP) Genotyping Companies Headquarters & Product Type
4.4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Companies Headquarters
4.4.2 Date of International Companies Enter into Single Nucleotide Polymorphism (SNP) Genotyping Market
4.4.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Companies Product & Service
4.4.4 Transversion Revenue Market Share of Single Nucleotide Polymorphism (SNP) Genotyping by Company
4.4.5 Transition Revenue Market Share of Single Nucleotide Polymorphism (SNP) Genotyping by Company
4.5 Global Single Nucleotide Polymorphism (SNP) Genotyping Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Illumina
5.1.1 Illumina Corporation Information
5.1.2 Illumina Description, Business Overview
5.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.1.4 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.1.5 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.1.6 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.1.7 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.1.8 Illumina Recent Developments
5.2 Affymetrix
5.2.1 Affymetrix Corporation Information
5.2.2 Affymetrix Description, Business Overview
5.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.2.4 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.2.5 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.2.6 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.2.7 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.2.8 Affymetrix Recent Developments
5.3 Applied Biosystems
5.3.1 Applied Biosystems Corporation Information
5.3.2 Applied Biosystems Description, Business Overview
5.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.3.4 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.3.5 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.3.6 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.3.7 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.3.8 Applied Biosystems Recent Developments
5.4 Agilent Technologies
5.4.1 Agilent Technologies Corporation Information
5.4.2 Agilent Technologies Description, Business Overview
5.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.4.4 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.4.5 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.4.6 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.4.7 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.4.8 Agilent Technologies Recent Developments
5.5 Beckman Coulter
5.5.1 Beckman Coulter Corporation Information
5.5.2 Beckman Coulter Description, Business Overview
5.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.5.4 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.5.5 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.5.6 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.5.7 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.5.8 Beckman Coulter Recent Developments
5.6 Roche
5.6.1 Roche Corporation Information
5.6.2 Roche Description, Business Overview
5.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.6.4 Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.6.5 Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.6.6 Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.6.7 Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.6.8 Roche Recent Developments
5.7 Qiagen
5.7.1 Qiagen Corporation Information
5.7.2 Qiagen Description, Business Overview
5.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.7.4 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.7.5 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.7.6 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.7.7 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.7.8 Qiagen Recent Developments
5.8 Luminex Corporation
5.8.1 Luminex Corporation Corporation Information
5.8.2 Luminex Corporation Description, Business Overview
5.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.8.4 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.8.5 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.8.6 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.8.7 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.8.8 Luminex Corporation Recent Developments
5.9 Enzo Life Sciences
5.9.1 Enzo Life Sciences Corporation Information
5.9.2 Enzo Life Sciences Description, Business Overview
5.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.9.4 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.9.5 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.9.6 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.9.7 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.9.8 Enzo Life Sciences Recent Developments
5.10 Bio-rad
5.10.1 Bio-rad Corporation Information
5.10.2 Bio-rad Description, Business Overview
5.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.10.4 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.10.5 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.10.6 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.10.7 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.10.8 Bio-rad Recent Developments
5.11 Sequenom
5.11.1 Sequenom Corporation Information
5.11.2 Sequenom Description, Business Overview
5.11.3 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.11.4 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.11.5 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.11.6 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.11.7 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.11.8 Sequenom Recent Developments
5.12 Ocimum Biosolutions
5.12.1 Ocimum Biosolutions Corporation Information
5.12.2 Ocimum Biosolutions Description, Business Overview
5.12.3 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.12.4 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.12.5 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.12.6 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.12.7 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.12.8 Ocimum Biosolutions Recent Developments
5.13 GE Healthcare
5.13.1 GE Healthcare Corporation Information
5.13.2 GE Healthcare Description, Business Overview
5.13.3 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.13.4 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.13.5 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.13.6 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.13.7 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.13.8 GE Healthcare Recent Developments
5.14 GenScript
5.14.1 GenScript Corporation Information
5.14.2 GenScript Description, Business Overview
5.14.3 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.14.4 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.14.5 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.14.6 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.14.7 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.14.8 GenScript Recent Developments
5.15 Douglas Scientific
5.15.1 Douglas Scientific Corporation Information
5.15.2 Douglas Scientific Description, Business Overview
5.15.3 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.15.4 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.15.5 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.15.6 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.15.7 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.15.8 Douglas Scientific Recent Developments
5.16 BGI
5.16.1 BGI Corporation Information
5.16.2 BGI Description, Business Overview
5.16.3 BGI Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.16.4 BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.16.5 BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.16.6 BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.16.7 BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.16.8 BGI Recent Developments
5.17 Beijing Sunbiotech
5.17.1 Beijing Sunbiotech Corporation Information
5.17.2 Beijing Sunbiotech Description, Business Overview
5.17.3 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.17.4 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.17.5 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.17.6 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.17.7 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.17.8 Beijing Sunbiotech Recent Developments
5.18 HuaGene Biotech
5.18.1 HuaGene Biotech Corporation Information
5.18.2 HuaGene Biotech Description, Business Overview
5.18.3 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.18.4 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.18.5 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.18.6 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.18.7 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.18.8 HuaGene Biotech Recent Developments
5.19 Generay Biotech
5.19.1 Generay Biotech Corporation Information
5.19.2 Generay Biotech Description, Business Overview
5.19.3 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.19.4 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.19.5 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.19.6 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.19.7 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.19.8 Generay Biotech Recent Developments
5.20 Benegene
5.20.1 Benegene Corporation Information
5.20.2 Benegene Description, Business Overview
5.20.3 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.20.4 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.20.5 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.20.6 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.20.7 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.20.8 Benegene Recent Developments
5.21 Shanghai Biochip
5.21.1 Shanghai Biochip Corporation Information
5.21.2 Shanghai Biochip Description, Business Overview
5.21.3 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.21.4 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.21.5 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.21.6 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.21.7 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.21.8 Shanghai Biochip Recent Developments
5.22 GENESKY
5.22.1 GENESKY Corporation Information
5.22.2 GENESKY Description, Business Overview
5.22.3 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.22.4 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.22.5 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.22.6 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.22.7 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.22.8 GENESKY Recent Developments
5.23 HD Biosciences
5.23.1 HD Biosciences Corporation Information
5.23.2 HD Biosciences Description, Business Overview
5.23.3 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
5.23.4 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2020-2025)
5.23.5 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2024
5.23.6 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2024
5.23.7 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2024
5.23.8 HD Biosciences Recent Developments
6 North America
6.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth 2020-2031
6.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Facts & Figures by Country (2020-2031)
6.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2020-2025)
6.4 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2020-2025)
7.4 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2020-2025)
8 Europe
8.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth 2020-2031
8.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Facts & Figures by Country (2020-2031)
8.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2020-2025)
8.4 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth 2020-2031
9.2 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Facts & Figures by Country (2020-2031)
9.3 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2020-2025)
9.4 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2020-2025)
10.4 Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Single Nucleotide Polymorphism (SNP) Genotyping Supply Chain Analysis
11.2 Single Nucleotide Polymorphism (SNP) Genotyping Key Raw Materials and Upstream Suppliers
11.3 Single Nucleotide Polymorphism (SNP) Genotyping Clients Analysis
11.4 Single Nucleotide Polymorphism (SNP) Genotyping Sales Channel and Sales Model Analysis
11.4.1 Single Nucleotide Polymorphism (SNP) Genotyping Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Single Nucleotide Polymorphism (SNP) Genotyping Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Single Nucleotide Polymorphism (SNP) Genotyping Distributors
12 Single Nucleotide Polymorphism (SNP) Genotyping Market Dynamics
12.1 Single Nucleotide Polymorphism (SNP) Genotyping Industry Trends
12.2 Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers
12.3 Single Nucleotide Polymorphism (SNP) Genotyping Market Challenges
12.4 Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Illumina Inc
Affymetrix Inc
Applied Biosystems
Agilent Technologies
Beckman Coulter
Roche
Qiagen NV
Luminex Corporation
Enzo Life Sciences
Bio Rad
Sequenom
Ocimum Biosolutions
GE Healthcare
GenScript
Douglas Scientific
BGI
Beijing Sunbiotech
HuaGene Biotech
Generay Biotech
Benegene
Shanghai Biochip
GENESKY
HD Biosciences
List of Tables
 Table 1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Revenue (US$ Million) in 2024
 Table 13. Global Single Nucleotide Polymorphism (SNP) Genotyping Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Single Nucleotide Polymorphism (SNP) Genotyping by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Nucleotide Polymorphism (SNP) Genotyping as of 2024)
 Table 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Companies Headquarters
 Table 16. Date of International Companies Enter into Single Nucleotide Polymorphism (SNP) Genotyping Market
 Table 17. Global Single Nucleotide Polymorphism (SNP) Genotyping Companies Product & Service
 Table 18. Global Single Nucleotide Polymorphism (SNP) Genotyping Mergers & Acquisitions, Expansion Plans
 Table 19. Illumina Corporation Information
 Table 20. Illumina Description and Business Overview
 Table 21. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 22. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Illumina Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 24. Illumina Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 25. Illumina Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 26. Illumina Recent Developments
 Table 27. Affymetrix Corporation Information
 Table 28. Affymetrix Description and Business Overview
 Table 29. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 30. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Affymetrix Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 32. Affymetrix Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 33. Affymetrix Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 34. Affymetrix Recent Developments
 Table 35. Applied Biosystems Corporation Information
 Table 36. Applied Biosystems Description and Business Overview
 Table 37. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 38. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Applied Biosystems Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 40. Applied Biosystems Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 41. Applied Biosystems Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 42. Applied Biosystems Recent Developments
 Table 43. Agilent Technologies Corporation Information
 Table 44. Agilent Technologies Description and Business Overview
 Table 45. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 46. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Agilent Technologies Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 48. Agilent Technologies Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 49. Agilent Technologies Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 50. Agilent Technologies Recent Developments
 Table 51. Beckman Coulter Corporation Information
 Table 52. Beckman Coulter Description and Business Overview
 Table 53. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 54. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Beckman Coulter Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 56. Beckman Coulter Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 57. Beckman Coulter Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 58. Beckman Coulter Recent Developments
 Table 59. Roche Corporation Information
 Table 60. Roche Description and Business Overview
 Table 61. Roche Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 62. Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Roche Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 64. Roche Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 65. Roche Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 66. Roche Recent Developments
 Table 67. Qiagen Corporation Information
 Table 68. Qiagen Description and Business Overview
 Table 69. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 70. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Qiagen Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 72. Qiagen Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 73. Qiagen Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 74. Qiagen Recent Developments
 Table 75. Luminex Corporation Corporation Information
 Table 76. Luminex Corporation Description and Business Overview
 Table 77. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 78. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. Luminex Corporation Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 80. Luminex Corporation Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 81. Luminex Corporation Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 82. Luminex Corporation Recent Developments
 Table 83. Enzo Life Sciences Corporation Information
 Table 84. Enzo Life Sciences Description and Business Overview
 Table 85. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 86. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. Enzo Life Sciences Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 88. Enzo Life Sciences Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 89. Enzo Life Sciences Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 90. Enzo Life Sciences Recent Developments
 Table 91. Bio-rad Corporation Information
 Table 92. Bio-rad Description and Business Overview
 Table 93. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 94. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. Bio-rad Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 96. Bio-rad Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 97. Bio-rad Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 98. Bio-rad Recent Developments
 Table 99. Sequenom Corporation Information
 Table 100. Sequenom Description and Business Overview
 Table 101. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 102. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Sequenom Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 104. Sequenom Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 105. Sequenom Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 106. Sequenom Recent Developments
 Table 107. Ocimum Biosolutions Corporation Information
 Table 108. Ocimum Biosolutions Description and Business Overview
 Table 109. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 110. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 111. Ocimum Biosolutions Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 112. Ocimum Biosolutions Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 113. Ocimum Biosolutions Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 114. Ocimum Biosolutions Recent Developments
 Table 115. GE Healthcare Corporation Information
 Table 116. GE Healthcare Description and Business Overview
 Table 117. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 118. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 119. GE Healthcare Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 120. GE Healthcare Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 121. GE Healthcare Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 122. GE Healthcare Recent Developments
 Table 123. GenScript Corporation Information
 Table 124. GenScript Description and Business Overview
 Table 125. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 126. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 127. GenScript Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 128. GenScript Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 129. GenScript Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 130. GenScript Recent Developments
 Table 131. Douglas Scientific Corporation Information
 Table 132. Douglas Scientific Description and Business Overview
 Table 133. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 134. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 135. Douglas Scientific Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 136. Douglas Scientific Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 137. Douglas Scientific Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 138. Douglas Scientific Recent Developments
 Table 139. BGI Corporation Information
 Table 140. BGI Description and Business Overview
 Table 141. BGI Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 142. BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. BGI Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 144. BGI Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 145. BGI Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 146. BGI Recent Developments
 Table 147. Beijing Sunbiotech Corporation Information
 Table 148. Beijing Sunbiotech Description and Business Overview
 Table 149. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 150. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 151. Beijing Sunbiotech Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 152. Beijing Sunbiotech Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 153. Beijing Sunbiotech Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 154. Beijing Sunbiotech Recent Developments
 Table 155. HuaGene Biotech Corporation Information
 Table 156. HuaGene Biotech Description and Business Overview
 Table 157. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 158. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 159. HuaGene Biotech Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 160. HuaGene Biotech Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 161. HuaGene Biotech Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 162. HuaGene Biotech Recent Developments
 Table 163. Generay Biotech Corporation Information
 Table 164. Generay Biotech Description and Business Overview
 Table 165. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 166. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 167. Generay Biotech Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 168. Generay Biotech Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 169. Generay Biotech Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 170. Generay Biotech Recent Developments
 Table 171. Benegene Corporation Information
 Table 172. Benegene Description and Business Overview
 Table 173. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 174. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 175. Benegene Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 176. Benegene Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 177. Benegene Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 178. Benegene Recent Developments
 Table 179. Shanghai Biochip Corporation Information
 Table 180. Shanghai Biochip Description and Business Overview
 Table 181. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 182. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 183. Shanghai Biochip Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 184. Shanghai Biochip Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 185. Shanghai Biochip Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 186. Shanghai Biochip Recent Developments
 Table 187. GENESKY Corporation Information
 Table 188. GENESKY Description and Business Overview
 Table 189. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 190. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 191. GENESKY Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 192. GENESKY Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 193. GENESKY Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 194. GENESKY Recent Developments
 Table 195. HD Biosciences Corporation Information
 Table 196. HD Biosciences Description and Business Overview
 Table 197. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product
 Table 198. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 199. HD Biosciences Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2024
 Table 200. HD Biosciences Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2024
 Table 201. HD Biosciences Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2024
 Table 202. HD Biosciences Recent Developments
 Table 203. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2020-2025) & (US$ Million)
 Table 204. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2026-2031) & (US$ Million)
 Table 205. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2020-2025) & (US$ Million)
 Table 206. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2020-2025) & (US$ Million)
 Table 207. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Region (2020-2025) & (US$ Million)
 Table 208. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Region (2026-2031) & (US$ Million)
 Table 209. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2020-2025) & (US$ Million)
 Table 210. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2020-2025) & (US$ Million)
 Table 211. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2020-2025) & (US$ Million)
 Table 212. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2026-2031) & (US$ Million)
 Table 213. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2020-2025) & (US$ Million)
 Table 214. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2020-2025) & (US$ Million)
 Table 215. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2020-2025) & (US$ Million)
 Table 216. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2026-2031) & (US$ Million)
 Table 217. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2020-2025) & (US$ Million)
 Table 218. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2020-2025) & (US$ Million)
 Table 219. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2020-2025) & (US$ Million)
 Table 220. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2026-2031) & (US$ Million)
 Table 221. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2020-2025) & (US$ Million)
 Table 222. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2020-2025) & (US$ Million)
 Table 223. Single Nucleotide Polymorphism (SNP) Genotyping Key Raw Materials, Industry Status and Trend
 Table 224. Single Nucleotide Polymorphism (SNP) Genotyping Key Raw Materials and Upstream Suppliers
 Table 225. Single Nucleotide Polymorphism (SNP) Genotyping Clients Status and Trend
 Table 226. Single Nucleotide Polymorphism (SNP) Genotyping Typical Clients
 Table 227. Single Nucleotide Polymorphism (SNP) Genotyping Distributors
 Table 228. Single Nucleotide Polymorphism (SNP) Genotyping Market Trends
 Table 229. Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers
 Table 230. Single Nucleotide Polymorphism (SNP) Genotyping Market Challenges
 Table 231. Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints
 Table 232. Research Programs/Design for This Report
 Table 233. Key Data Information from Secondary Sources
 Table 234. Key Data Information from Primary Sources


List of Figures
 Figure 1. Single Nucleotide Polymorphism (SNP) Genotyping Product Picture
 Figure 2. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type in 2024 & 2031
 Figure 4. Transversion Product Picture
 Figure 5. Transition Product Picture
 Figure 6. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application in 2024 & 2031
 Figure 8. Diagnostics
 Figure 9. Animal
 Figure 10. Plant
 Figure 11. Research
 Figure 12. Others
 Figure 13. Single Nucleotide Polymorphism (SNP) Genotyping Report Years Considered
 Figure 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Region: 2024 Versus 2031
 Figure 17. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Region (2020-2031)
 Figure 18. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share Forecast by Application (2020-2031)
 Figure 20. Transversion of Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application, 2024 VS 2031
 Figure 21. Transition of Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application, 2024 VS 2031
 Figure 22. Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Company (2024)
 Figure 23. Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Transversion Revenue Proportion by Company in 2024
 Figure 25. Transition Revenue Proportion by Company in 2024
 Figure 26. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue 2020-2031 (US$ Million)
 Figure 27. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2020-2025)
 Figure 28. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2020-2025)
 Figure 29. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue 2020-2031 (US$ Million)
 Figure 30. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Region (2020-2031)
 Figure 31. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2020-2025)
 Figure 32. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2020-2025)
 Figure 33. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 34. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Country (2020-2031)
 Figure 35. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2020-2025)
 Figure 36. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2020-2025)
 Figure 37. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Country (2020-2031)
 Figure 39. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2020-2025)
 Figure 40. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2020-2025)
 Figure 41. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Country (2020-2031)
 Figure 43. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2020-2025)
 Figure 44. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2020-2025)
 Figure 45. Single Nucleotide Polymorphism (SNP) Genotyping Supply Chain (Upstream and Downstream Market)
 Figure 46. Global Production Market Share of Single Nucleotide Polymorphism (SNP) Genotyping Raw Materials by Region in 2024
 Figure 47. Single Nucleotide Polymorphism (SNP) Genotyping Distribution Channels
 Figure 48. Global Single Nucleotide Polymorphism (SNP) Genotyping Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 49. Global Single Nucleotide Polymorphism (SNP) Genotyping Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 50. Bottom-up and Top-down Approaches for This Report
 Figure 51. Data Triangulation
 Figure 52. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Single Nucleotide Polymorphism SNP Genotyping and Analysis Market Research Report 2024
Global SNP Genotyping and Analysis Market Research Report 2025
Global Genotyping Kits Market Research Report 2024
Global SNP Microarray Testing and Analysis Market Research Report 2025
Global Genotyping Assay Market Insights Forecast to 2030
Global Genotyping for Agricultural Biotechnology Market Research Report 2024
Global Genotyping Test Market Research Report 2025
Global Plant Genotyping Market Research Report 2025
Global Allele Market Research Report 2024
Global Genotyping Test Devices Market Research Report 2025
Global Pharmacogenetics Testing Market Research Report 2025
Agrigenomics Genotyping Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global DNA Genomic Testing Market Research Report 2024
Global DNA Genetic Testing Kit Market Research Report 2024
Global Genetic Engineering Plant Genomics Market Research Report 2024
Global Plant Genotyping Equipment Market Research Report 2025
Genotyping Arrays Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Next Generation Sequencing Technology Market Research Report 2025
Global Nucleic Acid Analyzer Market Research Report 2024
Genetic Data Analysis Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions